Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL
- PMID: 16028929
- DOI: 10.1021/ja050122x
Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL
Abstract
We describe a general method for the mimicry of one face of an alpha-helix based on a terphenyl scaffold that spatially projects functionality in a manner similar to that of two turns of an alpha-helix. The synthetic scaffold reduces the flexibility and molecular weight of the mimicked protein secondary structure. We have applied this design to the development of antagonists of the alpha-helix binding protein Bcl-x(L). Using a sequential synthetic strategy, we have prepared a library of terphenyl derivatives to mimic the helical region of the Bak BH3 domain that binds Bcl-x(L). Fluorescence polarization assays were carried out to evaluate the ability of terphenyl derivatives to displace the Bcl-x(L)-bound Bak peptide. Terphenyl 14 exhibited good in vitro affinity with a K(i) value of 0.114 muM. These terphenyl derivatives were more selective at disrupting the Bcl-x(L)/Bak over the HDM2/p53 interaction, which involves binding of the N-terminal alpha-helix of p53 to HDM2. Structural studies using NMR spectroscopy and computer-aided docking simulations suggested that the helix binding area on the surface of Bcl-x(L) is the target for the synthetic ligands. Treatment of human embryonic kidney 293 (HEK293) cells with terphenyl derivatives resulted in the disruption of the binding of Bcl-x(L) to Bax in intact cells.
Similar articles
-
Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction.J Am Chem Soc. 2005 Apr 20;127(15):5463-8. doi: 10.1021/ja0446404. J Am Chem Soc. 2005. PMID: 15826183
-
Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry.J Am Chem Soc. 2002 Oct 9;124(40):11838-9. doi: 10.1021/ja026861k. J Am Chem Soc. 2002. PMID: 12358513
-
Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein.Bioorg Med Chem Lett. 2004 Mar 22;14(6):1375-9. doi: 10.1016/j.bmcl.2003.09.096. Bioorg Med Chem Lett. 2004. PMID: 15006365
-
alpha-Helix mimetics as inhibitors of protein-protein interactions.Biochem Soc Trans. 2008 Dec;36(Pt 6):1414-7. doi: 10.1042/BST0361414. Biochem Soc Trans. 2008. PMID: 19021566 Review.
-
How the Bcl-2 family of proteins interact to regulate apoptosis.Cell Res. 2006 Feb;16(2):203-13. doi: 10.1038/sj.cr.7310028. Cell Res. 2006. PMID: 16474435 Review.
Cited by
-
Rationally Designed Polypharmacology: α-Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl-1 and HDM2.ChemMedChem. 2020 Sep 16;15(18):1691-1698. doi: 10.1002/cmdc.202000278. Epub 2020 Jun 25. ChemMedChem. 2020. PMID: 32583936 Free PMC article.
-
BH3 mimetics to improve cancer therapy; mechanisms and examples.Drug Resist Updat. 2007 Dec;10(6):207-17. doi: 10.1016/j.drup.2007.08.002. Epub 2007 Oct 24. Drug Resist Updat. 2007. PMID: 17921043 Free PMC article. Review.
-
Building addressable libraries: site-selective Suzuki reactions on microelectrode arrays.Org Lett. 2009 Mar 19;11(6):1273-6. doi: 10.1021/ol900056u. Org Lett. 2009. PMID: 19239260 Free PMC article.
-
Pyrrole-based scaffolds for turn mimics.Org Lett. 2011 Mar 4;13(5):980-3. doi: 10.1021/ol103022m. Epub 2011 Jan 26. Org Lett. 2011. PMID: 21268601 Free PMC article.
-
Protein Domain Mimics as Modulators of Protein-Protein Interactions.Acc Chem Res. 2017 Jun 20;50(6):1313-1322. doi: 10.1021/acs.accounts.7b00130. Epub 2017 May 31. Acc Chem Res. 2017. PMID: 28561588 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials
Miscellaneous